Cabozantinib
HealthData.Gov
Updated Oct 29, 2026
About this dataset
CABOMETYX is a prescription medication containing cabozantinib, a kinase inhibitor that helps treat certain advanced cancers. It comes as oral tablets in strengths of 20 mg, 40 mg, and 60 mg, manufactured by Exelixis, Inc. This information was generated using AI and is provided for informational and research purposes only.
Data and resources (1)
- HTML
Cabozantinib
Access the FDA dataset for Cabozantinib — ANDA 208692 submitted by Mylan Institutional LLC
Modified Jun 29, 2026